Enjoy complimentary customisation on priority with our Enterprise License!
The amlodipine besylate market share is expected to increase to USD 217.26 million from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 3.6%.
The report extensively covers amlodipine besylate market segmentations by the following:
The amlodipine besylate market report offers information on several market vendors, including Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd. among others.
This amlodipine besylate market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches.
Download the Free Report Sample to Unlock the Amlodipine Besylate Market Size for the Forecast Period and Other Important Statistics
The rising incidence of hypertension is notably driving the amlodipine besylate market growth, although factors such as side effects on human health may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the amlodipine besylate industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Amlodipine Besylate Market Driver
Key Amlodipine Besylate Market Trend
Key Amlodipine Besylate Market Challenge
Thus, such life-threatening side effects may hamper the amlodipine besylate market growth during the forecast period.
This amlodipine besylate market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the amlodipine besylate market encompasses successful business strategies deployed by the key vendors. The amlodipine besylate market is fragmented and the vendors are deploying growth strategies such as developing cost-effective products, mergers and acquisitions, robust research and development, and geographical expansion to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The amlodipine besylate market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for the amlodipine besylate market in North America. Market growth in this region will be faster than the growth of the market in Rest of World (ROW).
Huge investments in the pharmaceutical business will facilitate the amlodipine besylate market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
In 2020, the outbreak of COVID-19 negatively impacted the regional market. However, in 2021, the initiation of vaccination drives contributed to the containment of the disease. This has eventually led to the lifting of lockdowns and the resumption of all the previously closed public and private business units in the region. Thus, such factors are expected to drive the growth of the amlodipine besylate market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The amlodipine besylate market share growth by the high blood pressure segment will be significant during the forecast period. High blood pressure is a common problem that can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. If not treated, high blood pressure can lead to serious health problems, such as heart attack, heart failure, stroke, kidney failure, and loss of vision. A high blood pressure patient must continue taking amlodipine even if they feel well. Such medication for high blood pressure will drive the amlodipine besylate market growth during the forecast period.
This report provides an accurate prediction of the contribution of all the segments to the growth of the amlodipine besylate market size and actionable market insights on post COVID-19 impact on each segment.
Technavio categorizes the amlodipine besylate market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the amlodipine besylate market during the forecast period.
Our report provides extensive information on the value chain analysis for the amlodipine besylate market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
Amlodipine Besylate Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.6% |
Market growth 2022-2026 |
$ 217.26 million |
Market structure |
Fragmented |
YoY growth (%) |
3.0 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Amsal Chem Pvt. Ltd., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., CENTURY PHARMACEUTICALS Ltd., Cipla Ltd., Dr. Reddys Laboratories Ltd., MOEHS IBERICA SL, Rakshit Drugs Pvt. Ltd., VPL Chemicals Pvt. Ltd., Changzhou Yabang Pharmaceutical Co. Ltd., Pfizer Inc., Apotex Inc., Lupin Ltd., Strides Pharma Science Ltd, Teva Pharmaceutical Industries Ltd., Chartwell Pharmaceuticals LLC, Synthon International Holding BV, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., and Orbion Pharmaceuticals Pvt. Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Application
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.